Storm HH, Mandres T, Friis S, Bang S. Cancer incidence in Denmark 1989. Copenhagen: Danish Cancer Society, 1989;24.
Griffin MR, Bergstalh EJ, Coffey RJ, Beart RW Jr, Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60: 2318–24.
Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980;45:2969–74.
Svendsen LB, Sørensen C, Kjersgaard P, Meisner S, Kjærgård J. The influence of age upon curative operation for colorectal cancer. Int J Colorectal Dis 1989;4: 123–7.
Metzger U. Adjuvant therapy for colorectal carcinoma. World J Surg 1991;15:576–82.
Moertel CG, Fleming TR, MacDonald JS,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352–8.
Wunderlich M, Schiessel R, Rainer H,et al. Effect of adjuvant chemotherapy—or immunotherapy on the prognosis of colorectal cancer operated for cure. Br J Surg 1985;(Suppl):S107-S110.
Barkla DH, Tutton PJ. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors. J Natl Cancer Inst 1981;67:1207–11.
Burtin C, Noirot C, Scheinemann P, Galoppin L, Sabolovic D, Bernard P. Clinical improvement in advanced cancer disease after treatment combining histamine and H-2 antihistaminics (ranitidine and cimetidine). Eur J Cancer Clin Oncol 1988;24:161–7.
Gifford RR, Voss BV, Ferguson RM. Cimetidine protection against lethal tumor challenge in mice. Surgery 1981;90:344–51.
Osband ME, Shen Y, Schlesinger M,et al. Successful tumor immunotherapy with cimetidine in mice. Lancet 1981;1:636–8.
Tønnesen H, Knigge U, Bülow S,et al. Effect of cimetidine on survival after gastric cancer. Lancet 1988;2: 990–1.
Dukes CE. The classification of cancer of the rectum. J Pathol 1932;35:323–33.
Peto R, Pike MC, Armitage P,et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. Br J Cancer 1976;34:585–612.
Machin D, Gardner MJ. Calculating confidence intervals for survival time analysis. BMJ 1988;296:1366–71.
Bartholeyn J, Fozard JR. Role of histamine in tumor development. Trends Pharmacol Sci 1985;6:123–5.
Garcia-Caballero M, Neugebauer E, Campos R, Nunez de Castro J, Vara-Thorbeck C. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 1988;23:357–60.
Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR. Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 1988;114:588–92.
Cole WH, Humphrey L. Need for immunologic stimulation during immunosuppression produced by major cancer surgery. Ann Surg 1985;202:9–20.
Sugarbaker PH. A perspective on the clinical research strategies in carcinoma of the large bowel. World J Surg 1991;15:609–16.
Weese JL, Ottery FD, Emoto SE. Do operations facilitate tumor growth? An experimental model in rats. Surgery 1986;100:273–7.
Tilly BC, Terloolen LG, Remori R,et al. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2+- mobilizing H1 receptors. J Cell Biol 1990;110:1211–5.
Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Possible role of histamine-2 receptor antagonists for adjuvant treatment in colorectal cancer. Eur J Surg 1991;157:437–41.
Balch CM, Dougherty PA, Cloud GA, Tilden AB. Prostaglandin E-2 mediated suppression of cellular immunity in colon cancer patients. Surgery 1984;95:71–6.
Kojima O, Fujita Y, Iwai N,et al. Studies on cell mediated immunity in patients with colorectal cancer: leucocyte migration inhibition test using allogenic 3 M KCl extract. Aust N Z J Surg 1981;51:434–9.
Hammer JH, Nielsen HJ, Moesgaard F, Kehlet H. Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res 1992;24:133–7.
Hansbrough JH, Zapata-Sirvent RL, Bender EM. Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg 1986;151:249–55.
Windle R, Bell PR, Shaw D. Five years results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 1987;74:569–72.
Laurie JA, Moertel CG, Fleming TR,et al. Surgical adjuvant therapy of the large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989;7:1447–56.
Wanebo HJ, Jun MY, Strong EW, Oettgen H. T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 1975;130:445–51.